News
Scientists say study findings indicate that TC IV cells may represent a therapeutic target for the treatment of food-associated allergic and inflammatory diseases.
What makes orange cats orange? For over 60 years, scientists have been searching for the answer. Researchers from Japan have ...
News broke yesterday that researchers in Philadelphia appear to have successfully treated a 6-month-old baby boy, called KJ, ...
1d
Pharmaceutical Technology on MSNAGC Biologics and Quell to progress Treg cell therapy developmentThe Milan Cell and Gene Center of Excellence at AGC Biologics will produce LVV material for Treg cell therapy candidates.
Immunosuppressive factors prevent killer T cells from defeating brain tumors that arise from primary breast cancer.
A decade ago, a clinical trial in the U.K. famously showed that children who were exposed to peanuts in the early months of ...
Thetis cells, a class of immune cells first described in 2022, play an essential and previously unknown role in suppressing inflammatory responses to food, a new study finds.
A decade ago, a clinical trial in the U.K. famously showed that children who were exposed to peanuts in the early months of ...
CCR8 is highly expressed on immunosuppressive regulatory T cells (Tregs) in various solid tumors, making it a potential target to enhance antitumor immunity and the efficacy of cancer therapies, ...
In a new study published in Cell Reports, researchers at the University of Freiburg reveal how a disordered protein segment helps connect two key steps of gene expression: the reading of genes and the ...
Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces the online ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results